Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Symbiotic cellulolytic bacteria from the gut of the subterranean termite Psammotermes hypostoma Desneux and their role in cellulose digestion.

Ali HRK, Hemeda NF, Abdelaliem YF.

AMB Express. 2019 Jul 17;9(1):111. doi: 10.1186/s13568-019-0830-5.

2.

Poly (bromocresol green) flakes-decorated pencil graphite electrode for selective electrochemical sensing applications and pharmacokinetic studies.

Gadallah MI, Ali HRH, Askal HF, Saleh GA.

Mater Sci Eng C Mater Biol Appl. 2019 Sep;102:634-645. doi: 10.1016/j.msec.2019.03.071. Epub 2019 Mar 23.

PMID:
31147035
3.

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

De Mattos-Arruda L, Sammut SJ, Ross EM, Bashford-Rogers R, Greenstein E, Markus H, Morganella S, Teng Y, Maruvka Y, Pereira B, Rueda OM, Chin SF, Contente-Cuomo T, Mayor R, Arias A, Ali HR, Cope W, Tiezzi D, Dariush A, Dias Amarante T, Reshef D, Ciriaco N, Martinez-Saez E, Peg V, Ramon Y Cajal S, Cortes J, Vassiliou G, Getz G, Nik-Zainal S, Murtaza M, Friedman N, Markowetz F, Seoane J, Caldas C.

Cell Rep. 2019 May 28;27(9):2690-2708.e10. doi: 10.1016/j.celrep.2019.04.098.

4.

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.

Abubakar M, Figueroa J, Ali HR, Blows F, Lissowska J, Caldas C, Easton DF, Sherman ME, Garcia-Closas M, Dowsett M, Pharoah PD.

Mod Pathol. 2019 Apr 11. doi: 10.1038/s41379-019-0270-4. [Epub ahead of print]

PMID:
30976105
5.

Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups.

Rueda OM, Sammut SJ, Seoane JA, Chin SF, Caswell-Jin JL, Callari M, Batra R, Pereira B, Bruna A, Ali HR, Provenzano E, Liu B, Parisien M, Gillett C, McKinney S, Green AR, Murphy L, Purushotham A, Ellis IO, Pharoah PD, Rueda C, Aparicio S, Caldas C, Curtis C.

Nature. 2019 Mar;567(7748):399-404. doi: 10.1038/s41586-019-1007-8. Epub 2019 Mar 13.

PMID:
30867590
6.

Quantifying Competition among Mitochondrial Protein Acylation Events Induced by Ethanol Metabolism.

Ali HR, Assiri MA, Harris PS, Michel CR, Yun Y, Marentette JO, Huynh FK, Orlicky DJ, Shearn CT, Saba LM, Reisdorph R, Reisdorph N, Hirschey MD, Fritz KS.

J Proteome Res. 2019 Apr 5;18(4):1513-1531. doi: 10.1021/acs.jproteome.8b00800. Epub 2019 Jan 31.

PMID:
30644754
7.

A single run, rapid polarity switching method for determination of 30 pharmaceuticals and personal care products in waste water using Q-Exactive Orbitrap high resolution accurate mass spectrometry.

Abou-Elwafa Abdallah M, Nguyen KH, Ebele AJ, Atia NN, Ali HRH, Harrad S.

J Chromatogr A. 2019 Mar 15;1588:68-76. doi: 10.1016/j.chroma.2018.12.033. Epub 2018 Dec 21.

PMID:
30587347
8.

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort.

Mukherjee A, Russell R, Chin SF, Liu B, Rueda OM, Ali HR, Turashvili G, Mahler-Araujo B, Ellis IO, Aparicio S, Caldas C, Provenzano E.

NPJ Breast Cancer. 2018 Mar 7;4:5. doi: 10.1038/s41523-018-0056-8. eCollection 2018.

9.

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

Abubakar M, Chang-Claude J, Ali HR, Chatterjee N, Coulson P, Daley F, Blows F, Benitez J, Milne RL, Brenner H, Stegmaier C, Mannermaa A, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RAEM, Seynaeve C, Figueroa J, Lissowska J, Hewitt S, Hooning MJ, Hollestelle A, Foekens R, Koppert LB, Investigators K, Bolla MK, Wang Q, Jones ME, Schoemaker MJ, Keeman R, Easton DF, Swerdlow AJ, Sherman ME, Schmidt MK, Pharoah PD, Garcia-Closas M.

Int J Cancer. 2018 Aug 15;143(4):746-757. doi: 10.1002/ijc.31352. Epub 2018 Mar 25.

10.

Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.

Álvarez-Fernández M, Sanz-Flores M, Sanz-Castillo B, Salazar-Roa M, Partida D, Zapatero-Solana E, Ali HR, Manchado E, Lowe S, VanArsdale T, Shields D, Caldas C, Quintela-Fandino M, Malumbres M.

Cell Death Differ. 2018 May;25(5):828-840. doi: 10.1038/s41418-017-0024-0. Epub 2017 Dec 11.

11.

Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer.

James FR, Jiminez-Linan M, Alsop J, Mack M, Song H, Brenton JD, Pharoah PDP, Ali HR.

BMC Cancer. 2017 Sep 20;17(1):657. doi: 10.1186/s12885-017-3585-x.

12.

A rapid Fourier transform infrared spectroscopic method for analysis of certain proton pump inhibitors in binary and ternary mixtures.

Khashaba PY, Ali HRH, El-Wekil MM.

Spectrochim Acta A Mol Biomol Spectrosc. 2018 Feb 5;190:10-14. doi: 10.1016/j.saa.2017.09.003. Epub 2017 Sep 5.

PMID:
28889052
13.

Development of a novel and cost-effective redox sensor for voltammetric determination of pantoprazole sodium during pharmacokinetic studies.

Khashaba PY, Ali HRH, El-Wekil MM.

R Soc Open Sci. 2017 Aug 9;4(8):170324. doi: 10.1098/rsos.170324. eCollection 2017 Aug.

14.

Corrigendum: p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.

van de Ven RAH, de Groot JS, Park D, van Domselaar R, de Jong D, Szuhai K, van der Wall E, Rueda OM, Ali HR, Caldas C, van Diest PJ, Hetzer MW, Sahai E, Derksen PWB.

Nat Commun. 2017 Sep 6;8:16030. doi: 10.1038/ncomms16030. eCollection 2017.

15.

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial.

Ali HR, Dariush A, Thomas J, Provenzano E, Dunn J, Hiller L, Vallier AL, Abraham J, Piper T, Bartlett JMS, Cameron DA, Hayward L, Brenton JD, Pharoah PDP, Irwin MJ, Walton NA, Earl HM, Caldas C.

Ann Oncol. 2017 Aug 1;28(8):1832-1835. doi: 10.1093/annonc/mdx266.

16.

Simultaneous voltammetric analysis of anti-ulcer and D2-antagonist agents in binary mixture using redox sensor and their determination in human serum.

Khashaba PY, Ali HRH, El-Wekil MM.

Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:733-741. doi: 10.1016/j.msec.2017.02.092. Epub 2017 Feb 24.

PMID:
28415523
17.

Novel polyacrylamide-based solid scale inhibitor.

Younes AA, El-Maghrabi HH, Ali HR.

J Hazard Mater. 2017 Jul 15;334:1-9. doi: 10.1016/j.jhazmat.2017.03.052. Epub 2017 Mar 29.

PMID:
28384554
18.

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, Aittomäki K, Liu J, Ali HR, Andrulis IL, Beckmann MW, Behrens S, Blows FM, Brenner H, Chang-Claude J, Couch FJ, Czene K, Fasching PA, Figueroa J, Floris G, Glendon G, Guo Q, Hall P, Hallberg E, Hamann U, Holleczek B, Hooning MJ, Hopper JL, Jager A, Kabisch M; kConFab/AOCS Investigators, Keeman R, Kosma VM, Lambrechts D, Lindblom A, Mannermaa A, Margolin S, Provenzano E, Shah M, Southey MC, Dennis J, Lush M, Michailidou K, Wang Q, Bolla MK, Dunning AM, Easton DF, Pharoah PD, Chenevix-Trench G, Blomqvist C, Nevanlinna H.

Oncotarget. 2017 Mar 14;8(11):18381-18398. doi: 10.18632/oncotarget.15110.

19.

p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis.

van de Ven RA, de Groot JS, Park D, van Domselaar R, de Jong D, Szuhai K, van der Wall E, Rueda OM, Ali HR, Caldas C, van Diest PJ, Hetzer MW, Sahai E, Derksen PW.

Nat Commun. 2016 Dec 22;7:13874. doi: 10.1038/ncomms13874. Erratum in: Nat Commun. 2017 Sep 06;8:16030.

20.

Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.

Ali HR, Chlon L, Pharoah PD, Markowetz F, Caldas C.

PLoS Med. 2016 Dec 13;13(12):e1002194. doi: 10.1371/journal.pmed.1002194. eCollection 2016 Dec.

21.

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.

Abubakar M, Orr N, Daley F, Coulson P, Ali HR, Blows F, Benitez J, Milne R, Brenner H, Stegmaier C, Mannermaa A, Chang-Claude J, Rudolph A, Sinn P, Couch FJ, Devilee P, Tollenaar RA, Seynaeve C, Figueroa J, Sherman ME, Lissowska J, Hewitt S, Eccles D, Hooning MJ, Hollestelle A, Martens JW, van Deurzen CH, Investigators K, Bolla MK, Wang Q, Jones M, Schoemaker M, Wesseling J, van Leeuwen FE, Van 't Veer L, Easton D, Swerdlow AJ, Dowsett M, Pharoah PD, Schmidt MK, Garcia-Closas M.

Breast Cancer Res. 2016 Oct 18;18(1):104.

22.

Gold Nanorods as Drug Delivery Vehicles for Rifampicin Greatly Improve the Efficacy of Combating Mycobacterium tuberculosis with Good Biocompatibility with the Host Cells.

Ali HR, Ali MR, Wu Y, Selim SA, Abdelaal HF, Nasr EA, El-Sayed MA.

Bioconjug Chem. 2016 Oct 19;27(10):2486-2492. Epub 2016 Sep 22.

PMID:
27595304
23.

Treatment of natural mammary gland tumors in canines and felines using gold nanorods-assisted plasmonic photothermal therapy to induce tumor apoptosis.

Ali MR, Ibrahim IM, Ali HR, Selim SA, El-Sayed MA.

Int J Nanomedicine. 2016 Sep 22;11:4849-4863. eCollection 2016.

24.

Targeting heat shock protein 70 using gold nanorods enhances cancer cell apoptosis in low dose plasmonic photothermal therapy.

Ali MR, Ali HR, Rankin CR, El-Sayed MA.

Biomaterials. 2016 Sep;102:1-8. doi: 10.1016/j.biomaterials.2016.06.017. Epub 2016 Jun 7.

PMID:
27318931
25.

Occurrence and distribution of antifouling biocide Irgarol-1051 in coral reef ecosystems, Zanzibar.

Sheikh MA, Juma FS, Staehr P, Dahl K, Rashid RJ, Mohammed MS, Ussi AM, Ali HR.

Mar Pollut Bull. 2016 Aug 15;109(1):586-590. doi: 10.1016/j.marpolbul.2016.05.035. Epub 2016 May 24.

PMID:
27234364
26.

The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.

Mendoza-Villanueva D, Balamurugan K, Ali HR, Kim SR, Sharan S, Johnson RC, Merchant AS, Caldas C, Landberg G, Sterneck E.

Oncogene. 2016 Dec 1;35(48):6166-6176. doi: 10.1038/onc.2016.156. Epub 2016 May 16.

27.

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Ali HR, Dariush A, Provenzano E, Bardwell H, Abraham JE, Iddawela M, Vallier AL, Hiller L, Dunn JA, Bowden SJ, Hickish T, McAdam K, Houston S, Irwin MJ, Pharoah PD, Brenton JD, Walton NA, Earl HM, Caldas C.

Breast Cancer Res. 2016 Feb 16;18(1):21. doi: 10.1186/s13058-016-0682-8.

28.

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Michaut M, Chin SF, Majewski I, Severson TM, Bismeijer T, de Koning L, Peeters JK, Schouten PC, Rueda OM, Bosma AJ, Tarrant F, Fan Y, He B, Xue Z, Mittempergher L, Kluin RJ, Heijmans J, Snel M, Pereira B, Schlicker A, Provenzano E, Ali HR, Gaber A, O'Hurley G, Lehn S, Muris JJ, Wesseling J, Kay E, Sammut SJ, Bardwell HA, Barbet AS, Bard F, Lecerf C, O'Connor DP, Vis DJ, Benes CH, McDermott U, Garnett MJ, Simon IM, Jirström K, Dubois T, Linn SC, Gallagher WM, Wessels LF, Caldas C, Bernards R.

Sci Rep. 2016 Jan 5;6:18517. doi: 10.1038/srep18517.

29.

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.

Sung H, Garcia-Closas M, Chang-Claude J, Blows FM, Ali HR, Figueroa J, Nevanlinna H, Fagerholm R, Heikkilä P, Blomqvist C, Giles GG, Milne RL, Southey MC, McLean C, Mannermaa A, Kosma VM, Kataja V, Sironen R, Couch FJ, Olson JE, Hallberg E, Olswold C, Cox A, Cross SS, Kraft P, Tamimi RM, Eliassen AH, Schmidt MK, Bolla MK, Wang Q, Easton D, Howat WJ, Coulson P, Pharoah PD, Sherman ME, Yang XR.

Br J Cancer. 2016 Feb 2;114(3):298-304. doi: 10.1038/bjc.2015.437. Epub 2015 Dec 17.

30.

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer.

Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DWY, Marass F, Gale D, Ali HR, Shah P, Contente-Cuomo T, Farahani H, Shumansky K, Kingsbury Z, Humphray S, Bentley D, Shah SP, Wallis M, Rosenfeld N, Caldas C.

Nat Commun. 2015 Nov 4;6:8760. doi: 10.1038/ncomms9760.

31.

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.

Candido Dos Reis FJ, Lynn S, Ali HR, Eccles D, Hanby A, Provenzano E, Caldas C, Howat WJ, McDuffus LA, Liu B, Daley F, Coulson P, Vyas RJ, Harris LM, Owens JM, Carton AF, McQuillan JP, Paterson AM, Hirji Z, Christie SK, Holmes AR, Schmidt MK, Garcia-Closas M, Easton DF, Bolla MK, Wang Q, Benitez J, Milne RL, Mannermaa A, Couch F, Devilee P, Tollenaar RA, Seynaeve C, Cox A, Cross SS, Blows FM, Sanders J, de Groot R, Figueroa J, Sherman M, Hooning M, Brenner H, Holleczek B, Stegmaier C, Lintott C, Pharoah PD.

EBioMedicine. 2015 May 9;2(7):681-9. doi: 10.1016/j.ebiom.2015.05.009. eCollection 2015 Jul.

32.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.

Sobral-Leite M, Wesseling J, Smit VT, Nevanlinna H, van Miltenburg MH, Sanders J, Hofland I, Blows FM, Coulson P, Patrycja G, Schellens JH, Fagerholm R, Heikkilä P, Aittomäki K, Blomqvist C, Provenzano E, Ali HR, Figueroa J, Sherman M, Lissowska J, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Phillips KA; kConFab/AOCS Investigators, Couch FJ, Olson JE, Vachon C, Visscher D, Brenner H, Butterbach K, Arndt V, Holleczek B, Hooning MJ, Hollestelle A, Martens JW, van Deurzen CH, van de Water B, Broeks A, Chang-Claude J, Chenevix-Trench G, Easton DF, Pharoah PD, García-Closas M, de Graauw M, Schmidt MK.

BMC Med. 2015 Jul 2;13:156. doi: 10.1186/s12916-015-0392-6.

33.

Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays.

Blows FM, Ali HR, Dawson SJ, Le Quesne J, Provenzano E, Caldas C, Pharoah PD.

Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):221-6. doi: 10.1097/PAI.0000000000000172. Erratum in: Appl Immunohistochem Mol Morphol. 2016 May-Jun;24(5):382.

34.

PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.

Ali HR, Glont SE, Blows FM, Provenzano E, Dawson SJ, Liu B, Hiller L, Dunn J, Poole CJ, Bowden S, Earl HM, Pharoah PD, Caldas C.

Ann Oncol. 2015 Jul;26(7):1488-93. doi: 10.1093/annonc/mdv192. Epub 2015 Apr 20.

PMID:
25897014
35.

Prognostic and predictive value of PDL1 expression in breast cancer.

Sabatier R, Finetti P, Mamessier E, Adelaide J, Chaffanet M, Ali HR, Viens P, Caldas C, Birnbaum D, Bertucci F.

Oncotarget. 2015 Mar 10;6(7):5449-64.

36.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.

Howat WJ, Blows FM, Provenzano E, Brook MN, Morris L, Gazinska P, Johnson N, McDuffus LA, Miller J, Sawyer EJ, Pinder S, van Deurzen CH, Jones L, Sironen R, Visscher D, Caldas C, Daley F, Coulson P, Broeks A, Sanders J, Wesseling J, Nevanlinna H, Fagerholm R, Blomqvist C, Heikkilä P, Ali HR, Dawson SJ, Figueroa J, Lissowska J, Brinton L, Mannermaa A, Kataja V, Kosma VM, Cox A, Brock IW, Cross SS, Reed MW, Couch FJ, Olson JE, Devillee P, Mesker WE, Seyaneve CM, Hollestelle A, Benitez J, Perez JI, Menéndez P, Bolla MK, Easton DF, Schmidt MK, Pharoah PD, Sherman ME, García-Closas M.

J Pathol Clin Res. 2014 Dec 4;1(1):18-32. doi: 10.1002/cjp2.3. eCollection 2015 Jan.

37.

Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer.

Wishart GC, Rakha E, Green A, Ellis I, Ali HR, Provenzano E, Blows FM, Caldas C, Pharoah PD.

BMC Cancer. 2014 Dec 3;14:908. doi: 10.1186/1471-2407-14-908.

38.

Genome-driven integrated classification of breast cancer validated in over 7,500 samples.

Ali HR, Rueda OM, Chin SF, Curtis C, Dunning MJ, Aparicio SA, Caldas C.

Genome Biol. 2014 Aug 28;15(8):431. doi: 10.1186/s13059-014-0431-1.

39.

Contamination of diuron in coastal waters around Malaysian Peninsular.

Ali HR, Arifin MM, Sheikh MA, Shazili NA, Bakari SS, Bachok Z.

Mar Pollut Bull. 2014 Aug 15;85(1):287-91. doi: 10.1016/j.marpolbul.2014.05.049. Epub 2014 Jun 13.

PMID:
24934440
40.

Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.

Ali HR, Provenzano E, Dawson SJ, Blows FM, Liu B, Shah M, Earl HM, Poole CJ, Hiller L, Dunn JA, Bowden SJ, Twelves C, Bartlett JM, Mahmoud SM, Rakha E, Ellis IO, Liu S, Gao D, Nielsen TO, Pharoah PD, Caldas C.

Ann Oncol. 2014 Aug;25(8):1536-43. doi: 10.1093/annonc/mdu191. Epub 2014 Jun 9.

PMID:
24915873
41.

Micellar electrokinetic chromatographic determination of rosuvastatin in rabbit plasma and evaluation of its pharmacokinetics and interaction with niacin.

El-Kommos ME, Mohamed NA, Ali HR, Abdel Hakiem AF.

Biomed Chromatogr. 2014 Dec;28(12):1828-38. doi: 10.1002/bmc.3227. Epub 2014 May 14.

PMID:
24828212
42.

Occurrence and distribution of antifouling biocide Irgarol-1051 in coastal waters of Peninsular Malaysia.

Ali HR, Arifin MM, Sheikh MA, Mohamed Shazili NA, Bachok Z.

Mar Pollut Bull. 2013 May 15;70(1-2):253-7. doi: 10.1016/j.marpolbul.2013.02.024. Epub 2013 Mar 11.

PMID:
23490347
43.

Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor.

Mohammed H, D'Santos C, Serandour AA, Ali HR, Brown GD, Atkins A, Rueda OM, Holmes KA, Theodorou V, Robinson JL, Zwart W, Saadi A, Ross-Innes CS, Chin SF, Menon S, Stingl J, Palmieri C, Caldas C, Carroll JS.

Cell Rep. 2013 Feb 21;3(2):342-9. doi: 10.1016/j.celrep.2013.01.010. Epub 2013 Feb 9.

44.

Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.

Ali HR, Irwin M, Morris L, Dawson SJ, Blows FM, Provenzano E, Mahler-Araujo B, Pharoah PD, Walton NA, Brenton JD, Caldas C.

Br J Cancer. 2013 Feb 19;108(3):602-12. doi: 10.1038/bjc.2012.558. Epub 2013 Jan 17.

45.

Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling.

Yuan Y, Failmezger H, Rueda OM, Ali HR, Gräf S, Chin SF, Schwarz RF, Curtis C, Dunning MJ, Bardwell H, Johnson N, Doyle S, Turashvili G, Provenzano E, Aparicio S, Caldas C, Markowetz F.

Sci Transl Med. 2012 Oct 24;4(157):157ra143. doi: 10.1126/scitranslmed.3004330. Erratum in: Sci Transl Med. 2012 Oct 24;4(157):161er6.

46.

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer.

Ali HR, Dawson SJ, Blows FM, Provenzano E, Pharoah PD, Caldas C.

Br J Cancer. 2012 May 22;106(11):1798-806. doi: 10.1038/bjc.2012.167. Epub 2012 Apr 26.

47.

Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin.

Ali HR, Alhalaweh A, Velaga SP.

Drug Dev Ind Pharm. 2013 May;39(5):625-34. doi: 10.3109/03639045.2012.671831. Epub 2012 Apr 5.

PMID:
22480325
48.

Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.

Quesne JL, Jones J, Warren J, Dawson SJ, Ali HR, Bardwell H, Blows F, Pharoah P, Caldas C.

J Pathol. 2012 Jul;227(3):306-14. doi: 10.1002/path.3983. Epub 2012 May 8.

PMID:
22294324
49.

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, Ali S, Chin SF, Palmieri C, Caldas C, Carroll JS.

Nature. 2012 Jan 4;481(7381):389-93. doi: 10.1038/nature10730.

50.

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.

Ali HR, Dawson SJ, Blows FM, Provenzano E, Pharoah PD, Caldas C.

Breast Cancer Res. 2011;13(6):R118. doi: 10.1186/bcr3061. Epub 2011 Nov 23.

Supplemental Content

Support Center